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The fully active semisynthetic enzyme formed by the non-covalent interaction of residues l-l 18 of bovine 
pancreatic ribonuclease and a synthetic tetradecapeptide containing residues 111-124 of the enzyme has 
allowed a direct test of the role of aspartic acid-121 in the functioning of the molecule. Replacement of 
this residue by asparagine results in a derivative that is 4.5% active against cytidine 2’ ,3’-cyclic phosphate 
at pH 7.0 under standard assay conditions. Further studies with the same substrate at pH 5.8 reveal that 
the reduced activity results entirely from a diminished catalytic efficiency and not from a decreased affinity 
for substrate. 
Bovine pancreatic ribonuclease Active site 
1. INTRODUCTION 
Several lines of evidence have indicated that 
aspartic acid-121 functions at the active site of 
bovine pancreatic ribonuclease. Limited peptic 
digestion removes the 4 COOH-terminal residues 
of the molecule as a tetrapeptide, leaving a 
derivative, RNase l-120, that exhibits only 0.5% 
of the activity of the native enzyme [1,2]. Although 
loss of Asp-121 is one feasible basis for the reduced 
activity, the results of alkylation studies [2,3] in- 
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Abbreviations: RNase l-120, polypeptide composed of 
residues l-120 of ribonuclease; RNase l-l 18, polypep- 
tide composed of residues 1 - 118 of ribonuclease; RNase 
111-124, synthetic tetradecapeptide composed of 
residues 111-124 of ribonuclease; RNase 111-124 
(Asn-121), synthetic tetradecapeptide composed of 
residues 111-124 of ribonuclease with Asp-121 replaced 
by Asn; RNase l-l 18 : 111-124, the non-covalent com- 
plex of RNase l-l 18 and RNase 111-124; RNase 
l-118:111-124(Asn-121). thenon-covalent complexof 
RNase 1-118 and RNase 111-124 (Asn-121); Boc, 
tert-butyloxycarbonyl 
Semisynthetic enzyme Chemical modification 
traduced the possibility that a subtle conforma- 
tional change might actually be the cause of inac- 
tivation in this derivative. More recently, authors 
in [4,5] detected by both X-ray and neutron dif- 
fraction a hydrogen bond between carboxyl ODl 
of Asp-121 and nitrogen NE2 of histidine-119, a 
well-established and critical active site residue. In 
35 species of mammalian ribonucleases Asp-121 is 
a residue that remains completely constant [6], a 
situation generally interpreted as indicating func- 
tional significance of some sort. 
We report here an experimental test of the role 
of Asp-121 that has involved the preparation and 
characterization of a semisynthetic derivative of 
ribonuclease in which Asp-121 has been replaced 
by an asparagine residue. The semisynthetic system 
utilized was first developed and explored in [7,8]; 
this consists of residues 1-118 of the original 
molecule noncovalently complexed with a 
chemically synthesized tetradecapeptide comprised 
of residues 111-124 of the original molecule. The 
procedure is summarized in fig. 1. The complex has 
a binding constant of 5 x lo6 M-’ at pH 6.0 in the 
presence of substrate and exhibits 98% of the en- 
zymatic activity of native ribonuclease [8]. 
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\l-----no-m--124] PEPSIN+ p=zFq + 1121-_1241 
RIBONUCLEASE A P.NASE l-120 (0.5% active) 
1 
CARBOXYPEPTIDASE A 
RNASE ill--124 
RNASE l-llB:lll--124 
(98% active) (or a structural analog thereof) 
Fig. 1. Scheme of semisynthetic r bonuclease system. 
2. MATERIALS AND METHODS 
RNase A (RAF OLA, salt-free) and pepsin (lot 
PM36c675, 2700 units/mg) were purchased from 
Worthington. Carboxypeptidase A (lot 45~8030, 
57 units/mg) was from Sigma. 
Amino acid intermediates were all obtained 
from Bachem. They included the a-Boc derivatives 
of valine, 0-benzylserine, alanine, phenylalanine, 
N”“-DNP-histidine, proline, 0-benzyltyrosine, 
glycine, y-benzylglutamate and the p-nitrophenyl 
ester of asparagine. 
Dicyclohexylcarbodiimide (Pierce), 4-dimethyl- 
aminopyridine (99vo, Aldrich), trimethylamine 
(Eastman Organics) and trifluoroacetic acid (99Y0, 
Pierce) were used without further purification. 
Pyridine (Baker, AR) was distilled from ninhydrin 
(1 g/l) before use. Dichloromethane (certified 
ACS, Fisher) was stored over anhydrous CaClz 
before use. N,N-Dimethylformamide (certified 
ACS, Fisher) was stored over type 4A molecular 
sieves (Davison) before use. All other reagents and 
solvents were the highest grade available and were 
used without further purification. 
2.1. Preparation of RNase I-118 
RNase l-l 18 was prepared by successive diges- 
tion of RNase A with pepsin and carboxypeptidase 
A as in [2,3,9]. Stock solutions of RNase 1-118 
and of RNase l-120 were characterized and stan- 
dardized by amino acid analysis of acid 
hydrolysates (6 N HCl, llO”C, 22 h, in vacua) of 
aliquot samples and were stored at - 20°C. Amino 
acid analyses were performed with a Beckman 
amino acid analyzer. Specific activity against 
cytidine 2’ ,3 ’ -cyclic phosphate was determined, 
directly in the case of RNase I-120 (product of 
pepsin digestion) and after the addition of a solu- 
tionofRNaselll-124inthecaseofRNasel-118 
[lo]. At high mole ratios of RNase 111-124, the 
lot of RNase l-l 18 used here exhibited 85% of the 
activity expected from a corresponding amount of 
RNase A. 
2.2. Synthesis of RNase III-124 (Asn-121) 
The tetradecapeptide was prepared by the use of 
solid-phase peptide synthetic methods [ 1 I- 131. 
Commercial chloromethylated polystyrene-co-l % 
divinylbenzene resin (Lab Systems, lot 
PPMR-45K, 1.09 mmol Cl/g) was converted to the 
corresponding hydroxymethylated erivative as in 
[ 14,151. Elemental analysis (Galbraith) indicated 
no Cl in the product. Reaction of a 15.4 g sample 
of this resin with 2.0 M excess of Boc-L-valine [15] 
provided a product containing 0.76 mmol 
valine/g. Acetylation of the remaining hydrox- 
ymethyl groups with pyridine-acetic anhydride 
(1: 1, v/v) [16], was followed by standard cycles of 
deprotection, neutralization and DCC-mediated 
coupling (except in the case of Asn-121 and -113 
where unmediated reaction of the p-nitrophenyl 
ester was utilized to provide the protected 
1Cresidue chain) [13]. The completeness of each 
coupling step was monitored by the use of the 
Kaiser test [17]. Repeat coupling was required to 
complete the addition of Ser-123, Asn-121, 
Phe-120, His-119, Pro-117, and Asn-113. In the 
case of Ser-123 and Phe-120 the second coupling 
was followed by acetylation with pyridine-acetic 
anhydride (1: 1, v/v) [ 161. Removal of the ti”‘- 
DNP group from His-119 by thiolysis [18] was 
followed by acidolysis of the remaining protected 
groups as well as cleavage from the resin with HBr 
in trifluoroacetic acid [13]. The crude peptide was 
purified first by gel filtration in 0.15 M pyridine 
acetate (pH 5.5) on a 200 x 2.0 cm column of 
Sephadex G-25, 50-150rm, followed by ion- 
exchange chromatography in a gradient of 
pyridine acetate buffers on a 70 x 2.0 cm column 
of SP-Sephadex C-25, 40-120pm (fig.2). Stock 
solutions of bands A and B from the ion-exchange 
chromatography were characterized and standar- 
dized by amino acid analysis (see table 1) and 
stored at -20°C. 
2.3. Activity determinations 
Enzymatic activity was measured spec- 
trophotometrically at 25°C as in [lo] using cytidine 
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2 ’ ,3 ’ -cyclic phosphate (Schwarz-Mann, lot 
616231) as the substrate. Maximal regenerable ac- 
tivity with a given substrate concentration was 
determined from a series of measurements with a 
fixed concentration of RNase 1-118 and pro- 
gressively higher concentrations of tetradecapep- 
tide. Extrapolation of a double-reciprocal plot of 
observed initial velocity vs mole ratio of peptide to 
RNase 1-118 provided the desired value (fig.3). 
3. RESULTS AND DISCUSSION 
Fractionation of the gel-filtered, crude RNase 
111-124 (Asn-121) on SP-Sephadex provided two 
bands, A and B, both of which had amino acid 
compositions after acid hydrolysis corresponding 
to that expected for RNase 111-124 (Asn-121) 
(fig.2 and table 1). The maximal regenerable activi- 
ty obtainable with band A or B was determined 
under standard assay conditions by measuring the 
initial rate of hydrolysis of cytidine 2’,3’-cyclic 
phosphate at progressively higher mole ratios of 
the material in A or B to RNase l-l 18 and ex- 
trapolating a double-reciprocal plot of the data to 
an infinite mole ratio (fig.3). Compared to the 
value obtained with the parent semisynthetic om- 
omo- 
A700 
Fig.2. SP-Sephadex chromatography of gel-filtered 
RNase 111-124 (Am-121). Column, 70 x 2.0 cm SP- 
Sephadex C-25 (40-120pm); initial buffer, 550 ml of 
0.05 M pyridine acetate (pH 3.55); limiting buffer, 
550 ml of 0.25 M pyridine acetate (pH 4.08); at arrow, 
elution by undiluted limiting buffer began. Flow rate, 
36 ml/h; temperature, 55°C. Folin-Lowry determin- 
ations on dried aliquots of fractions (O---O); pH of 
selected fractions (H). Amino acid analyses (see 
table 1) and assays of activity in the presence of RNase 
l-l 18 (see text and fig.3) were performed on fraction 
pools A and B. 
Table 1 
Amino acid composition? of bands A and B from the 
ion-exchange chromatography of RNase 111-124 
(Asn-121) on SP-Sephadex 
Amino acid Band A Band B Residues 
111-124 
of RNaseb 
Histidine 0.97 0.81 1 
Aspartic acid 2.24 2.09 2c 
Serine 1.27 1.14 1 
Glutamic acid 0.96 1.03 1 
Proline 1.92 1.77 2 
Glycine 1.09 1.09 1 
Alanine 1.10 1.17 1 
Valine 3.00 3.07 3 
Tyrosine 0.87 0.86 1 
Phenylalanine 0.89 0.90 1 
a Values were determined after 22 h hydrolysis and are 
given as molar ratios. No corrections for hydrolytic 
losses or incomplete hydrolysis have been applied 
b From [23] 
’ In ribonuclease one residue is aspartic acid and the 
second is asparagine; in RNase 111-124 (Asn-121) 
both residues are asparagine 
plex, i.e., RNase l-118:111-124, band A 
generated 4.5% activity and band B, 4.8% 
activity. 
The presence of more than one band of peptide 
material having an amino acid composition, after 
acid hydrolysis, corresponding to RNase 1 1 l- 124 
(Asn-121) reflects the presence of partially 
deblocked product in the material placed on the 
SP-Sephadex column. By analogy with effluent 
patterns from previous syntheses, band A should 
be the completely deblocked peptide. In any event, 
only one acid-labile side chain block, viz., the O- 
benzyl block on Ser-123, could conceivably affect 
the activity of the complex. 
We may conclude, therefore, that substitution 
of Asp-121 by asparagine in RNase 1-118:111- 
124 has caused a substantial reduction in the rate 
of substrate turnover in this enzyme as measured 
under standard assay conditions. 
The kinetic behavior of the complex formed by 
the material in band A and RNase l-1 18 was fur- 
ther characterized by the measurement at pH 5.8 
of the initial rates of hydrolysis of cytidine 
2’,3’-cyclic phosphate as a function of substrate 
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Fig.3. Reciprocal of the initial rate of hydrolysis of 
cytidine 2’ ,3’-cyclic phosphate under standard assay 
conditions as a function of progressively higher mole 
ratios of RNase 111-124 to RNase 118 (mole ratio 
varied between 5.1 and 25.7). The concentration of 
RNase l-118 was 0.181 pM throughout the series. The 
points are the mean of 3 determinations and the line is 
the least-square analysis of the data. 
concentration, These measurements revealed that 
the reduced activity results entirely from a 
diminished catalytic efficiency and not from a 
decreased affinity for substrate. 
Characterization of the histidine proton NMR 
spectrum of the complex in a manner analogous to 
that recently reported for the parent RNase 
1-118: 111-124 1191 should assist in defining the 
immediate basis for the reduced activity. If 
suitable crystals can be grown, X-ray diffraction 
analysis will be applied, as it has been both to 
RNase l-l 18 : 111-124 and the catalytically defec- 
tive Leu-120 derivative [20-221. 
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